Although the PKG level in PA was downregulated in PAH-MCT, the application of the PKG activator 8-Br-cGMP reversed the increased responsiveness to U46619 in PAH-MCT (Figure 4D). This evidence concerns the gene PRKG1 and pulmonary arterial hypertension.